已收录 268921 条政策
 政策提纲
  • 暂无提纲
Thromboxane Biosynthesis and its Inhibition in Man
[摘要] The principal product of arachidonic acid in the platelet is thromboxane A2 This compound is the most potent endogenous platelet agonist and vasoconstrictor known in man. Thromboxane A has been implicated in diverse human diseases in which platelet activation and vasospasm are known to occur. There has therefore been considerable interest in the development of therapeutic regimens designed to inhibit thromboxane biosynthesis. The studies described in this thesis investigated endogenous formation of thromboxane in human syndromes of platelet activation and examined the biochemical and functional effects of different approaches to inhibition of thromboxane production in health and disease.
[发布日期]  [发布机构] University:University of Glasgow
[效力级别]  [学科分类] 
[关键词] Medicine, Biochemistry [时效性] 
   浏览次数:4      统一登录查看全文      激活码登录查看全文